Merck Halts Another Winrevair Study Early

 
• By Joseph Haas
  
Merck 1200
Merck & Co. ends a second Phase III Winrevair trial early
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Therapy Areas